India genomics market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.0 Billion by 2033, exhibiting a growth rate (CAGR) of 16.10% during 2025-2033. The emerging shift towards personalized or precision medicine, where treatments are tailored to an individual's genetic makeup, is driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 2.2 Billion |
Market Forecast in 2033
|
USD 9.0 Billion |
Market Growth Rate 2025-2033 | 16.10% |
Genomics is a scientific discipline that involves the comprehensive study of an organism's complete set of genes, known as its genome. It encompasses the analysis of DNA sequences to understand the structure, function, and organization of genes within an organism. Advancements in genomics have revolutionized biology and medicine, enabling researchers to explore the genetic basis of traits, diseases, and evolution. Techniques like DNA sequencing have allowed the decoding of entire genomes, providing insights into the diversity and intricacies of life at the molecular level. Genomic information has applications in personalized medicine, where genetic variations are used to tailor treatments to individual patients. Additionally, it contributes to fields such as agriculture, forensics, and conservation, influencing the understanding of the genetic underpinnings of diverse biological processes.
The genomics market in India is experiencing unprecedented growth, driven by several key factors. Firstly, the increasing prevalence of chronic diseases has propelled the demand for advanced genomic solutions, as genomics plays a pivotal role in understanding the genetic basis of various disorders. Additionally, the decreasing costs of DNA sequencing technologies have significantly expanded accessibility, fostering widespread adoption. Moreover, collaborative initiatives between research institutions, pharmaceutical companies, and healthcare providers have accelerated genomic research, creating a synergistic environment for market expansion. Furthermore, the rising awareness and appreciation of personalized medicine have fueled the demand for genomics, as it enables tailoring medical treatments based on individual genetic profiles. In tandem, advancements in bioinformatics and data analytics have enhanced the interpretation of genomic information, making it more clinically relevant. The convergence of these technological breakthroughs has not only propelled research endeavors but has also spurred the development of innovative diagnostic tools and therapeutic interventions. In conclusion, a confluence of factors, including the surge in chronic diseases, cost-effective sequencing technologies, collaborative research efforts, personalized medicine trends, and technological advancements, collectively serve as potent drivers propelling the remarkable growth of the genomics market in India.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on component, application, technology, and end user.
Component Insights:
The report has provided a detailed breakup and analysis of the market based on the component. This includes products (instruments and software and consumables and reagents) and services (core genomics services, NGS-based services, biomarker translation services, computational services, and others).
Application Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes functional genomics, epigenomics, biomarkers discovery, pathway analysis, and others.
Technology Insights:
The report has provided a detailed breakup and analysis of the market based on the technology. This includes sequencing, microarray, polymerase chain reaction, nucleic acid extraction and purification, and others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes research centers, hospitals and clinics, pharmaceutical and biotechnology companies, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, West and Central India, South India, and East and Northeast India.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Components Covered |
|
Applications Covered | Functional Genomics, Epigenomics, Biomarkers Discovery, Pathway Analysis, Others |
Technologies Covered | Sequencing, Microarray, Polymerase Chain Reaction, Nucleic Acid Extraction and Purification, Others |
End Users Covered | Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others |
Regions Covered | North India, West and Central India, South India, East and Northeast India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: